Key result
A large-scale genome-wide meta-analysis identified 14 genetic susceptibility loci associated with PCOS, including 3 novel loci, demonstrating shared genetic architecture across different diagnostic criteria.
Meta-Analysis (n=113,238)
Yes
This large-scale GWAS meta-analysis identifies novel genetic loci for PCOS and demonstrates a shared genetic architecture between PCOS and metabolic traits including coronary artery disease, regardless of diagnostic criteria.
Answers are grounded in this paper and cite their sources.
May guide cardiometabolic risk assessment in PCOS; extends shared genetic architecture with CAD across criteria.
Polycystic ovary syndrome (PCOS) is a disorder characterized by hyperandrogenism, ovulatory dysfunction and polycystic ovarian morphology. Affected women frequently have metabolic disturbances including insulin resistance and dysregulation of glucose homeostasis. PCOS is diagnosed with two different sets of diagnostic criteria, resulting in a phenotypic spectrum of PCOS cases. The genetic similarities between cases diagnosed with different criteria have been largely unknown. Previous studies in Chinese and European subjects have identified 16 loci associated with risk of PCOS. We report a meta-analysis from 10,074 PCOS cases and 103,164 controls of European ancestry and characterisation of PCOS related traits. We identified 3 novel loci (near PLGRKT, ZBTB16 and MAPRE1 ), and provide replication of 11 previously reported loci. Identified variants were associated with hyperandrogenism, gonadotropin regulation and testosterone levels in affected women. Genetic correlations with obesity, fasting insulin, type 2 diabetes, lipid levels and coronary artery disease indicate shared genetic architecture between metabolic traits and PCOS. Mendelian randomization analyses suggested variants associated with body mass index, fasting insulin, menopause timing, depression and male-pattern balding play a causal role in PCOS. Only one locus differed in its association by diagnostic criteria, otherwise the genetic architecture was similar between PCOS diagnosed by self-report and PCOS diagnosed by NIH or Rotterdam criteria across common variants at 13 loci.
No takes yet. Share an insight, caveat, or question.
Day et al. (2018) conducted a meta-analysis in Polycystic Ovary Syndrome (n=113,238). Genetic susceptibility loci (SNPs) vs. Controls (individuals without PCOS) was evaluated on Identification of genetic susceptibility loci associated with PCOS (p=< 5.0 x 10-8). A large-scale genome-wide meta-analysis identified 14 genetic susceptibility loci associated with PCOS, including 3 novel loci, demonstrating shared genetic architecture across different diagnostic criteria.
Synapse has enriched 8 closely related papers on similar clinical questions. Consider them for comparative context: